1. Parker TS, McNamara DJ, Brown CD, Kolb R, Ahrens Jr EH (1984) Plasma mevalonate as a measure of cholesterol synthesis in man. J Clin Invest 74: 795?804
2. Wuttke H, Papalexiou P, Kasper FR (1983) Zum optimalen Einnahmezeitpunkt von Lipanthyl R250 Retard Kapseln. Therapiewoche 33: 6913?6922
3. Peters JR, Hunninghake DB (1985) Effect of time of administration of cholestyramine on plasma lipids and lipoproteins. Artery 13: 1?6
4. Illingworth DR (1986) Comparative efficacy of once versus twice daily mevinolin in the therapy of familial hypercholesterolemia. Clin Pharmacol Ther 40: 338?343
5. Hanefeld M, Lang PD, Fischer S, Leonhardt W, Bergman S, Jaroß W (1988) Effects of bezafibrate sustained release formulation on plasma lipoproteins in patients with hypercholesterolemia. Importance of timing of tablet intake for efficacy. Drug Res 38: 1835?1837